Abstract: This article focuses on the consensus and tracking problem of nonlinear multiagent systems under communication delays, and proposes a distributed predictive control scheme, which is ...

Patients with stage 3 colorectal cancer who tested MRD-positive with Signatera after surgery saw a meaningful survival ...

If you've had stomach pain recently, you might have wondered how to check if you have appendicitis at home. Appendicitis is the most common cause of abdominal pain that results in surgery in the ...

In April 2025, the U.S. Food and Drug Administration (FDA) released its Roadmap to Reducing Animal Testing in Preclinical Safety Studies—a landmark initiative that lays out a plan to make animal ...

The FDA’s emerging framework represents more than a regulatory update; it is a paradigm shift toward human-relevant, ...

By fusing behavioral data, real-time analytics and generative AI, the industry is entering a new era: attention hacking at ...

Proteomics International has secured a US patent for its PromarkerEso, a breakthrough blood test enabling early detection of ...

You know you've changed, but family gatherings pull you right back into old patterns. Here's why your brain does this and ...

Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.

Its tests aren’t perfect, but they’re better predictors of college performance than anything anyone else is using.

Adaptive test is starting to gain traction for high-performance computing and AI chips as test programs that rely on static limits and fixed test sequences reach their practical limits.

A retrospective real-world analysis presented at the 2025 ASH Annual Meeting and Exposition showed that circulating tumor DNA (ctDNA) detected at the end of treatment (EOT) was a prognostic indicator ...